Your search has returned a large number of results. Try searching for a more specific term or phrase.
Site Map
Home
Our Company
About Alnylam
Leadership
Diversity, Equity & Inclusion
Patient Access Philosophy
Corporate Responsibility
Grants & Giving
Investigator Initiated Studies (IIS)
Our…
Our Science
OUR PIPELINE
Our robust pipeline of investigational RNAi therapeutics is focused on diseases with high unmet medical need which fall into four main therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious…,
PATIENTS COME FIRST
While we’re driven by science, we’re motivated by people because for us, this is personal. Whether we're working to develop the first treatment for a disease or a better one, patients are the center of all we do.…,
Job Seekers
This is your moment to join us
We're 1,700+ smart, passionate, "change the world" kind of people who believe deeply in the power and potential of our technology and what we're building as a company. If you are looking for a…
Our Science
ABOUT CLINICAL TRIALS
There is a lot to know about clinical trials and much to discuss with your health care provider when considering clinical trial participation. The following information can get you started.
What Is a…, Clinical Trials Risks and Benefits?
Clinical trials are not without risk—the investigational medicine being tested might prove ineffective or cause side effects that researchers did not anticipate. The decision to participate in a clinical trial…
Our Science
ALNYLAM POLICY ON CLINICAL TRIAL TRANSPARENCY
Our Commitment
At Alnylam, innovative science focused on helping patients is at the core of who we are, and trust, honesty, and integrity are deeply important to how we operate.…
Our Science
DIVERSITY, EQUITY & INCLUSION
IN OUR CLINICAL TRIALS
Not all people respond to a medicine in the same way. Diversity of age, sex, race, ethnicity, and other factors in clinical trials is critical in evaluating the…
Our Science
CLINICAL TRIALS
People Power Progress in the Treatment of Disease
Innovative science is only part of the equation when it comes to developing new medicines. Clinical research relies on partnerships with health care…
You are now leaving Alnylam.com
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to SiteYou are now leaving Alnylam.com
You will be directed to another Alnylam website that may contain information about specific treatment(s), news and more.
Proceed to Site
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site